Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/3/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Patrick Loustau

Wrong Patrick Loustau?

President

Phone: (617) ***-****  HQ Phone
Zafgen Inc
175 Portland St 4Th Floor
Boston , Massachusetts 02114
United States

Company Description: Zafgen is a nimble, capital efficient virtual company that brings together leading experts in obesity and metabolic disease to address the underserved and growing...   more
Background

Employment History

Board Memberships and Affiliations

21 Total References
Web References
Patrick ...
ir.zafgen.com, 3 Sept 2014 [cached]
Patrick Loustau
...
Patrick Loustau President
Mr. Loustau has more than 20 years of experience in US and global management with up to $10.7B P&L in the biopharmaceutical industry. He has broad experience in... read more
...
Image of Patrick Loustau
...
Patrick Loustau President
Mr. Loustau has more than 20 years of experience in US and global management with up to $10.7B P&L in the biopharmaceutical industry. He has broad experience in creating and implementing differentiated global and market strategies, from clinical development through life cycle management and business development.
Most recently, Mr. Loustau was the SVP for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb. He had previously been with Novo Nordisk, where he held roles as the SVP for Global Marketing & Medical Affairs (based in Copenhagen), VP, Sales Force and Managed Care/Government Affairs (in Princeton, NJ), President & GM (Toronto), Regional Business Director Sales and Senior Director Marketing Diabetes (both also in Princeton), and Project Leader - Business Acceleration (for Germany, USA & Canada). Mr. Loustau joined Novo Nordisk as a Neurology Brand Manager and then became Marketing Director. He began his career with Parke-Davis in Paris, France as an HR and Training Manager.
Mr. Loustau is a member of the Board of Directors for the Greater New York Chapter of the American Diabetes Association and has participated in numerous athletic fundraising events for healthcare education and research.
Management Team - About Us - Zafgen
www.zafgen.com, 3 Sept 2014 [cached]
Patrick Loustau
President
Mr. Loustau has more than 20 years of experience in US and global management with up to $10.7B P&L in the biopharmaceutical industry. He has... read more
Patrick Loustau
President
Mr. Loustau has more than 20 years of experience in US and global management with up to $10.7B P&L in the biopharmaceutical industry. He has broad experience in creating and implementing differentiated global and market strategies, from clinical development through life cycle management and business development.
Most recently, Mr. Loustau was the SVP for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb. He had previously been with Novo Nordisk, where he held roles as the SVP for Global Marketing & Medical Affairs (based in Copenhagen), VP, Sales Force and Managed Care/Government Affairs (in Princeton, NJ), President & GM (Toronto), Regional Business Director Sales and Senior Director Marketing Diabetes (both also in Princeton), and Project Leader - Business Acceleration (for Germany, USA & Canada). Mr. Loustau joined Novo Nordisk as a Neurology Brand Manager and then became Marketing Director. He began his career with Parke-Davis in Paris, France as an HR and Training Manager.
Mr. Loustau has participated in numerous athletic fundraising events for healthcare education and research.
Zafgen Appoints Patrick ...
ir.zafgen.com, 1 July 2014 [cached]
Zafgen Appoints Patrick Loustau as President | Previous Release Zafgen Appoints Patrick Loustau as President (NASDAQ:ZFGN) Facebook
...
Zafgen Appoints Patrick Loustau as President
Mr. Loustau Brings Over 20 Years of US and Global Management Experience
CAMBRIDGE, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today announced the appointment of Patrick Loustau to the position of President. Mr. Loustau has broad experience in creating and implementing differentiated global and market strategies, from clinical development through life cycle management and business development. Most recently, he was the Senior Vice President for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb, where he built a strong diabetes presence, growing sales from $158M to $1.6B in three years through both organic and external growth strategies that ultimately led to the $7B acquisition of Amylin.
"The addition of Patrick to our management team comes at a very exciting time for Zafgen," said Thomas Hughes, Ph.D., Chief Executive Officer, Zafgen, Inc.
...
"Patrick is a seasoned professional, having shaped commercial strategy for major metabolic disease products in the U.S. and global markets. His business experience will prove especially valuable as we further develop Zafgen's corporate strategy and solidify our position as an emerging leader in the development of therapeutics for difficult-to-treat metabolic diseases."
Mr. Loustau was previously with Novo Nordisk, where he held the most recent role of Senior Vice President for Global Marketing & Medical Affairs (based in Copenhagen). While at Novo Nordisk, he rebuilt its global marketing and medical affairs team, implemented a globally aligned go-to-market model and increased diabetes sales in the U.S. by 76% in two years.
Mr. Loustau began his career with Parke-Davis in Paris, France, as a Human Resources and Training Manager. He attended the General Manager Program through Harvard Business School's Executive Education track.
"Zafgen represents a unique value proposition in the biotech field and has the potential to dramatically impact patients and their families, ultimately transforming the way obesity and related metabolic diseases are treated," said Mr. Loustau.
Zafgen Appoints Patrick ...
www.marketscanners.com [cached]
Zafgen Appoints Patrick Loustau as President | Read more... Zafgen Appoints Patrick Loustau as President MarketScanners.com
...
Zafgen Appoints Patrick Loustau as President
Zafgen Appoints Patrick Loustau as President
...
CAMBRIDGE, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today announced the appointment of Patrick Loustau to the position of President. Mr. Loustau has broad experience in creating and implementing differentiated global and market strategies, from clinical development through life cycle management and business development. ost recently, he was the Senior Vice President for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb, where he built a strong diabetes presence, growing sales from $158M to $1.6B in three years through both organic and external growth strategies that ultimately led to the $7B acquisition of Amylin.
"The addition of Patrick to our management team comes at a very exciting time for Zafgen," said Thomas Hughes, Ph.D., Chief Executive Officer, Zafgen, Inc.
...
"Patrick is a seasoned professional, having shaped commercial strategy for major metabolic disease products in the U.S. and global markets. is business experience will prove especially valuable as we further develop Zafgen's corporate strategy and solidify our position as an emerging leader in the development of therapeutics for difficult-to-treat metabolic diseases."
Mr. Loustau was previously with Novo Nordisk, where he held the most recent role of Senior Vice President for Global Marketing & Medical Affairs (based in Copenhagen). While at Novo Nordisk, he rebuilt its global marketing and medical affairs team, implemented a globally aligned go-to-market model and increased diabetes sales in the U.S. by 76% in two years.
Mr. Loustau began his career with Parke-Davis in Paris, France, as a Human Resources and Training Manager. e attended the General Manager Program through Harvard Business School's Executive Education track.
"Zafgen represents a unique value proposition in the biotech field and has the potential to dramatically impact patients and their families, ultimately transforming the way obesity and related metabolic diseases are treated," said Mr. Loustau.
Zafgen Appoints Patrick ...
ir.zafgen.com [cached]
Zafgen Appoints Patrick Loustau as President
Other People with the name "Loustau":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304